The Translational Research Institute (TRI), Brisbane has become the first centre in Australia and the Asia Pacific region to adopt the Livecyte™ Cell Imaging and Analysis system. TRI was formed to enhance collaboration between science, healthcare and industry with the purpose of accelerating the application of innovative scientific research to improve healthcare outcomes. The Institute, […]

Feeling limited and underwhelmed by your flow cytometer automation? Stratedigm’s all new Open API gives you the freedom you deserve and the future-proof growth you need. There are many components that can be apart of an automation system like shakers, liquid handlers, incubators, storage, schedulers, and analyzers. And with Stratedigm’s Open API, you can expand […]

Avalon Forms Subsidiary U.S. Company, GenExosome Technologies Inc., for the Global Advancement of Exosome Technology for Diagnosis and Treatment of Diseases FREEHOLD, NJ — Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that its majority-owned subsidiary GenExosome Technologies Inc. (GenExosome) acquired 100% of the outstanding capital stock of Beijing Jieteng (Beijing GenExosome) […]

Call to unite stakeholders and experts Leuven – The world-leading research and innovation hub in nano-electronics and digital technologies imec announced today that is has joined ORCHID, a European initiative that will establish a European infrastructure to enable coordinated development, production and implementation of Organs-on-Chips by a consortium of academic and private partners. In total six […]

Charles River to license PDX lines to InSphero for development of 3D InSight™ PDX Microtissues, expansion of in vitro oncology services.  PDF Version Schlieren, Switzerland InSphero AG and Charles River Laboratories International, Inc. today announced a partnership through which Charles River will license its collection of patient-derived xenograft (PDX) tumors to InSphero. Additionally, Charles River will leverage InSphero’s […]

Researchers can now access immune cell products and other related services from Astarte Biologics on the Scientist.com marketplace San Diego, Cailfornia Scientist.com, the life science industry’s leading online marketplace for outsourced scientific services, announced today that it has partnered with Astarte Biologics, a leading provider of immune cell products and research services for immunology and […]

Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, appointed Katherine Eade and Thomas Loewald as Class II directors of the Board of Directors, effective as of October 24, 2017. Ms. Eade is Director, M&A Law and Transactions at Corning.  Prior to […]

Fluidigm to distribute histoCAT™, the first multiparameter Imaging Mass Cytometry™ software that combines leading-edge image and cytometry analysis tailored to highly multiplexed imaging data in a simple and easy-to-use format. SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced that it has entered into a distribution agreement with the University of Zurich to offer histoCAT™ software for multiparameter tissue […]

The Hyperion™ Imaging System provides translational researchers with an unprecedented view of complex cellular phenotypes and their relationships in the tissue microenvironment. SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of the Hyperion™ Imaging System, significantly expanding the number of protein markers that researchers can simultaneously detect in tumors and tissues. Providing unprecedented visualization of […]

Munich, Germany – ibidi introduces a fast, new web-based tool, ACAS (Automated Cellular Analysis System), which offers extremely quick and reliable analysis of wound healing and angiogenesis assays. This lean and efficient software is the latest addition to ibidi’s already innovative product portfolio, which covers the whole assay workflow—from sample preparation to analysis.   The ACAS […]